Fawzi Kabil M, Nasr M, El-Sherbiny IM. Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. Eur J Pharm Biopharm 2021;167:9-37. [PMID: 34271117 DOI: 10.1016/j.ejpb.2021.07.003][Reference Citation Analysis]
3
Rahim MA, Madni A, Tahir N, Jan N, Shah H, Khan S, Ullah R, Bari A, Khan MS. Mild Hyperthermia Responsive Liposomes for Enhanced In Vitro and In Vivo Anticancer Efficacy of Doxorubicin against Hepatocellular Carcinoma. Pharmaceutics 2021;13:1310. [PMID: 34452271 DOI: 10.3390/pharmaceutics13081310][Reference Citation Analysis]